Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia

GBT Announces Plans to Seek Expanded Labeling for Oxbryta® (voxelotor) to Treat Children Ages 4 to 11 Years with Sickle Cell Disease

Constellation Pharmaceuticals Announces Appointment of Dr. Jeffrey Humphrey as Chief Medical Officer

Magenta Therapeutics Presents Data Supporting Immune Reset For Autoimmune Diseasesm

Jounce Therapeutics Regains Worldwide Rights to JTX-8064 from Bristol Myers Squibb